IO Biotech | 8-K:重大事件
04/26 17:29 (美东)
IO Biotech | DEF 14A:股东委托书决议
04/24 16:11 (美东)
IO Biotech | ARS:年度报告
04/24 16:10 (美东)
IO Biotech | DEFA14A:其他
04/24 16:09 (美东)
IO Biotech | 10-K/A:年度报表(修正版)
03/22 17:08 (美东)
IO Biotech | 4:持股变动声明-高管 Zocca Mai-Britt
03/18 16:32 (美东)
IO Biotech | 4:持股变动声明-高管 Smith Devin Whittemore
03/18 16:27 (美东)
IO Biotech | 4:持股变动声明-高管 Sullivan Amy
03/18 16:26 (美东)
IO Biotech | 4:持股变动声明-高管 Burkavage Brian
03/18 16:26 (美东)
IO Biotech | 4:持股变动声明-高管 Ahmad Qasim Iftikhar
03/18 16:22 (美东)
IO Biotech | S-8:员工福利计划证券登记
03/11 16:58 (美东)
IO Biotech | 10-K:年度报表
03/05 17:23 (美东)
IO Biotech | 8-K:IO Biotech公布2023年第四季度和年终业绩
03/05 16:53 (美东)
IO Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
02/14 09:03 (美东)
IO Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Novo Holdings A/S(11.1%)
02/13 21:36 (美东)
IO Biotech | 4:持股变动声明-股东 Novo Holdings A/S
02/13 21:36 (美东)
IO Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-BANK OF AMERICA CORPORATION(2.8%)
02/13 19:41 (美东)
IO Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-HBM Healthcare Investments (Cayman) Ltd.(6.0%)
02/13 16:49 (美东)
IO Biotech | SC 13G/A:超过5%持股股东披露文件(修正)
02/13 16:35 (美东)
IO Biotech | 144:拟议出售证券
02/09 21:35 (美东)
暂无数据
暂无数据